Term
name the 4 loop diuretics |
|
Definition
Furosemide, Bumetanide, Ethacrynic Acid, Torsemide (FBET) |
|
|
Term
|
Definition
block Cl- and Na+ reabsorption and prevent passive H2O reabsorption in thick ascending LOH |
|
|
Term
loop diuretics - 4 indications |
|
Definition
pulmonary edema, edematous states (CHF, cirrhosis, nephrosis), HTN, hypercalcemia |
|
|
Term
Loop diruetics - 2 major AEs and 4 others |
|
Definition
Major: dehydration and hypotension
Others: electrolyte imbalance (all Hypo esp. K+), hyperglycemia, hyperuricemia, ototoxicity |
|
|
Term
thiazide diuretics all have an... |
|
Definition
unsubsituted sulfonamide group |
|
|
Term
list 5 thiazide diuretics |
|
Definition
Hydrochlorothiazide, chlorothiazide, diazoxide, indapamide, metolazone |
|
|
Term
|
Definition
inhibit NaCl reabsorption from luminal side of epitheial cells in DCT |
|
|
Term
thiazide diuretics - 3 clinical indications |
|
Definition
HTN (DOC for initial HTN, hypercalciuria, nephrogenic diabetes insipidus |
|
|
Term
|
Definition
similar to those of loop diuretics
hypercalcemia/hyperglycemia, NO ototoxicty |
|
|
Term
list 3 potassium-sparing diuretics
Sprinolactone MOA |
|
Definition
spironolactone, eplerenone, triameterene
blocks action of aldosterone via competitive antagonism of cytoplasmic mineralcorticoid receptors in distal nephron (DCT + CT)
*active metabolite = canrenone |
|
|
Term
|
Definition
states of aldosterone excess inc. CHF, cirrhosis, nephrotic syndrome |
|
|
Term
|
Definition
hyperkalemia, hyperchloremic metabolic acidosis, gynecomastia/impotence |
|
|
Term
|
Definition
blocks binding of aldosterone to mineralcorticoid receptor |
|
|
Term
eplerenone principal risk |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
influences Na+/K+ exchange in distal nephron |
|
|
Term
triameterene clinical indications (2) |
|
Definition
HTN, mild edema
**usually combined w/another diuretic such as a thiazide one **Amiloride blocks luminal Na+ channels |
|
|
Term
CARBONIC ANHYDRASE INHIBITORS - MOA and predominant site |
|
Definition
catalyze dehydration of H2CO3, which is a critical step in HCO3 reabsorption-->inhibition of Carb. anhydrase causes diuresis and reduction in total body HCO3 stores site - luminal membrane of PCT
**used very infrequently |
|
|
Term
list 4 Carbonic Anhydrase Inhibitors |
|
Definition
acetazolamide (common), dichlorphenamide, methazolamide, dorzolamide
**SO2NH2 group essential for activity |
|
|
Term
clinical actions of CAIs (4) |
|
Definition
increase urine volume, decrease HCO3- in blood (metabolic acidosis), hypokalemia, alkaline pH urine |
|
|
Term
4 clinical indications CAIs |
|
Definition
glaucoma, urinary alkalinization, reduction of total body HCO3 stores, acute mountain sickness |
|
|
Term
|
Definition
hypokalemia, COTRAINDICATED in cirrhosis |
|
|
Term
OSMOTIC DIURETICS - name 1 |
|
Definition
|
|
Term
|
Definition
creates osmotic force w/in lumen of nephron-->prevents H2O reabsorption in those segments freely permeable to H2O (PCT and descending loop of Henle) |
|
|
Term
osmotic diuretics - clinical indications (2) |
|
Definition
prophylaxis of renal shutdown, reduction of intracranial or intraocular pressure (ex. head trauma post-op neurosurgery)
**only administered IV |
|
|
Term
most common electrolyte that gets screwed up and 3 high content sources |
|
Definition
potassium
dried figs, molasses, seaweed |
|
|
Term
2 important potassium replacement products |
|
Definition
potassium chloride (most concentrated), potassium bicarbonate |
|
|
Term
what fluid gives physiological osmolality and is administered IV? |
|
Definition
|
|
Term
Magnesium Sulfate indications (4) |
|
Definition
seizure prevention in eclampsia and pre-eclasmpsia
tx cardiac arrhythmias (hypomagnesemia, torsades de pointes)
soft-tissue injuries
status asthmaticus |
|
|
Term
When is magnesium sulfate administered IV vs topical? (also available oral and IM) |
|
Definition
IV - w/cardiac issues
topical - w/soft tissue injuries |
|
|
Term
3 types of oral magnesium replacement |
|
Definition
Mg Oxide/chloride/lactate |
|
|